US5523215A
(en)
*
|
1985-03-28 |
1996-06-04 |
Chiron Corporation |
Enhanced purification and expression of insoluble recombinant proteins
|
US5698390A
(en)
*
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
HUT54896A
(en)
*
|
1989-03-17 |
1991-04-29 |
Chiron Corp |
Process for producing aquous diagnosticum and vaccine of nanbv
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
GEP20002164B
(en)
*
|
1989-05-18 |
2000-07-10 |
Novartis Vaccines & Diagnostic |
Oligomers, method for detecting of hcv sequence, kit for its detecting, method for production of the blood free from hcv
|
EP0416725A3
(en)
*
|
1989-07-14 |
1991-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
|
CA2065287C
(en)
*
|
1989-09-15 |
1999-12-21 |
Tatsuo Miyamura |
New hcv isolates
|
US5372928A
(en)
*
|
1989-09-15 |
1994-12-13 |
Chiron Corporation |
Hepatitis C virus isolates
|
US7166287B1
(en)
|
1989-12-18 |
2007-01-23 |
Glaxo Wellcome Inc. |
Viral agent
|
IT1242183B
(it)
*
|
1989-12-18 |
1994-02-16 |
Wellcome Found |
Polipeptidi del virus dell'epatite non-a e non-b, post-trasfusionali, procedimento di produzione e corredo per il saggio dei relativi acidi nucleici virali.
|
US5308750A
(en)
*
|
1989-12-22 |
1994-05-03 |
Abbott Laboratories |
Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
|
AU638304B2
(en)
*
|
1989-12-22 |
1993-06-24 |
Abbott Laboratories |
Hepatitis c assay
|
EP0435229A1
(en)
*
|
1989-12-27 |
1991-07-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
|
KR940000755B1
(ko)
*
|
1990-02-16 |
1994-01-29 |
유나이티드 바이오메디칼 인코오포레이티드 |
Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
|
US5747239A
(en)
*
|
1990-02-16 |
1998-05-05 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5106726A
(en)
*
|
1990-02-16 |
1992-04-21 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV
|
DE69133402T2
(de)
*
|
1990-04-04 |
2004-11-11 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Protease von hepatitis-c-virus
|
AU7679491A
(en)
*
|
1990-04-04 |
1991-10-30 |
Protos, Inc. |
Hepatitis c virus protease inhibitors
|
JP2733138B2
(ja)
†
|
1990-04-04 |
1998-03-30 |
カイロン コーポレイション |
抗hcv抗体の免疫アッセイに使用するc型肝炎ウイルス(hcv)抗原の組合せ
|
US5443965A
(en)
*
|
1990-04-06 |
1995-08-22 |
Genelabs Incorporated |
Hepatitis C virus epitopes
|
CA2044296A1
(en)
*
|
1990-06-12 |
1991-12-13 |
Hiroaki Okamoto |
Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
JP3050395B2
(ja)
*
|
1990-06-12 |
2000-06-12 |
国立感染症研究所長 |
C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
|
CA2045326A1
(en)
*
|
1990-06-25 |
1991-12-26 |
Hiroto Okayama |
Non-a, non-b, hepatitis virus particles
|
EP0464287A1
(en)
*
|
1990-06-25 |
1992-01-08 |
The Research Foundation for Microbial Diseases of Osaka University |
Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
|
US5747339A
(en)
*
|
1990-06-25 |
1998-05-05 |
Research Foundation For Microbial Diseases Of Osaka |
Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
|
WO1992000328A1
(en)
*
|
1990-06-30 |
1992-01-09 |
Akzo N.V. |
Non-a non-b sequences
|
EP0468657A3
(en)
*
|
1990-07-09 |
1992-02-05 |
Tonen Corporation |
Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
|
ES2100185T3
(es)
*
|
1990-07-11 |
1997-06-16 |
Shionogi & Co |
Secuencia de adnc y deteccion del virus de la hepatitis c.
|
CA2047792C
(en)
*
|
1990-07-26 |
2002-07-02 |
Chang Y. Wang |
Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
|
WO1992002642A1
(en)
*
|
1990-08-10 |
1992-02-20 |
Chiron Corporation |
Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
|
JP3114731B2
(ja)
*
|
1990-08-14 |
2000-12-04 |
国立感染症研究所長 |
C型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
|
US6172189B1
(en)
*
|
1990-08-24 |
2001-01-09 |
Abbott Laboratories |
Hepatitis C assay utilizing recombinant antigens
|
CA2049679C
(en)
*
|
1990-08-24 |
2005-06-21 |
Sushil G. Devare |
Hepatitis c assay utilizing recombinant antigens
|
EP0544838A4
(en)
*
|
1990-08-25 |
1997-09-10 |
New York Blood Center Inc |
Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
|
US7863008B2
(en)
|
1990-08-25 |
2011-01-04 |
Bioprocess Pty Ltd. |
Method for detecting NANBV associated seroconversion
|
IE65107B1
(en)
*
|
1990-10-05 |
1995-10-04 |
Akzo Nv |
Peptides immunochemically reactive with antibodies directed against hepatitis Non-A Non-B virus
|
DK0770679T4
(da)
*
|
1990-11-03 |
2010-05-10 |
Siemens Healthcare Diagnostics |
HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
|
EP0556320B1
(en)
*
|
1990-11-07 |
1999-03-24 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis c virus and method for using the same
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
DE69133382T3
(de)
*
|
1990-11-08 |
2009-10-08 |
Novartis Vaccines and Diagnostics, Inc.(n.d.Ges.d.Staates Delaware), Emeryville |
Asialoglycoproteine des Hepatitis C-Virus
|
JP2945759B2
(ja)
|
1990-11-08 |
1999-09-06 |
カイロン コーポレイション |
C型肝炎ウイルスアシアロ糖タンパク質
|
EP0485209A1
(en)
*
|
1990-11-08 |
1992-05-13 |
Immuno Japan Inc. |
Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
|
US6274148B1
(en)
*
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
JPH06504431A
(ja)
*
|
1990-11-08 |
1994-05-26 |
カイロン コーポレイション |
C型肝炎ウイルスアシアロ糖タンパク質
|
WO1992009634A1
(en)
*
|
1990-11-29 |
1992-06-11 |
Toray Industries, Incorporated |
Non-a non-b hepatitis virus antigen protein
|
EP0488812B1
(en)
*
|
1990-11-30 |
1999-06-09 |
Immuno Japan Inc. |
Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
ES2138784T3
(es)
*
|
1990-12-14 |
2000-01-16 |
Innogenetics Nv |
Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
|
US6007982A
(en)
*
|
1990-12-14 |
1999-12-28 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
US5910404A
(en)
|
1990-12-14 |
1999-06-08 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
DE4041304A1
(de)
*
|
1990-12-21 |
1992-06-25 |
Mikrogen Molekularbiol Entw |
Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren
|
JP3483555B2
(ja)
*
|
1991-01-31 |
2004-01-06 |
アボット・ラボラトリーズ |
推定hcvエンベロープ領域に対するモノクローナル抗体およびその使用方法
|
DE69200512T2
(de)
*
|
1991-03-01 |
1995-03-09 |
Akzo Nv |
Mit Antikörper gegen Hepatitis non-A, non-B-Virus immunochemische reaktive Peptide.
|
DE69216333T2
(de)
*
|
1991-03-26 |
1997-07-10 |
Dade Int Inc |
Nicht-a, nicht-b hepatitis test
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
EP0510952A1
(en)
*
|
1991-04-26 |
1992-10-28 |
Immuno Japan Inc. |
Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
SK284205B6
(sk)
*
|
1991-05-08 |
2004-10-05 |
Chiron Corporation |
Prirodzene sa nevyskytujúca nukleová kyselina, spôsob tvorby hybridizačného produktu a spôsob detekcie genotypov HCV
|
US6190864B1
(en)
|
1991-05-08 |
2001-02-20 |
Chiron Corporation |
HCV genomic sequences for diagnostics and therapeutics
|
FR2677372B1
(fr)
*
|
1991-06-06 |
1994-11-10 |
Pasteur Institut |
Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
|
WO1992022655A1
(en)
|
1991-06-10 |
1992-12-23 |
Lucky Limited |
Hepatitis c diagnostics and vaccines
|
CA2070952A1
(en)
*
|
1991-06-11 |
1992-12-12 |
Makoto Seki |
Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
|
WO1992022571A1
(en)
*
|
1991-06-13 |
1992-12-23 |
Baxter Diagnostics Inc. |
Immunoassay for non-a non-b hepatitis
|
DE69232871T2
(de)
*
|
1991-06-24 |
2003-05-08 |
Chiron Corp |
Polypeptide des hepatitis c-virus (hiv)
|
IT1249685B
(it)
*
|
1991-07-19 |
1995-03-09 |
Sorin Biomedica Spa |
Medoto per la rivelazione di anticorpi contro il virus dell'epatite c e corredi per la sua realizzazione
|
IT1249684B
(it)
*
|
1991-07-19 |
1995-03-09 |
Sorin Biomedica Spa |
Epitopi della proteina env del virus dell'epatite c.
|
AU2513592A
(en)
*
|
1991-08-21 |
1993-03-16 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens to ns1
|
WO1993004089A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens from ns5 region
|
DE69227776T2
(de)
*
|
1991-08-21 |
1999-07-01 |
Abbott Lab |
Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
|
WO1993004087A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens to c-100 region
|
EP0787807B1
(en)
*
|
1991-08-27 |
2003-05-28 |
F. Hoffmann-La Roche Ag |
Primers and probes for hepatitis C detection
|
US5427909A
(en)
*
|
1991-09-09 |
1995-06-27 |
Immuno Japan Inc. |
Oligonucleotides and determination system of HCV genotypes
|
DE69232859T2
(de)
*
|
1991-09-13 |
2003-04-10 |
Chiron Corp |
Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
|
CA2119013A1
(en)
†
|
1991-09-16 |
1993-04-01 |
Richard R. Lesniewski |
Hepatitis c assay
|
AU2683792A
(en)
*
|
1991-09-16 |
1993-04-27 |
Genelabs Technologies, Inc. |
Peptide based hepatitis c virus immunoassays
|
ZA927243B
(en)
*
|
1991-10-07 |
1994-01-26 |
Akzo Nv |
Non-A, Non-B peptides
|
JP3158177B2
(ja)
*
|
1991-10-08 |
2001-04-23 |
国立感染症研究所長 |
C型肝炎診断薬
|
ZA927837B
(en)
*
|
1991-10-15 |
1994-03-11 |
Akzo Nv |
Monoclonal antibodiesto hepatitis C virus
|
WO1993009253A1
(en)
*
|
1991-11-07 |
1993-05-13 |
Baxter Diagnostics Inc. |
Epitope mapping ot the c33c region of hcv
|
CA2123875C
(en)
|
1991-11-21 |
2005-05-24 |
Peter Simmons |
Hepatitis-c virus testing
|
WO1993011158A2
(en)
*
|
1991-12-06 |
1993-06-10 |
Akzo Nobel N.V. |
Non-a, non-b peptides
|
US5811246A
(en)
*
|
1991-12-17 |
1998-09-22 |
The Research Foundation Of State University Of New York |
Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization
|
WO1993015193A1
(en)
*
|
1992-01-31 |
1993-08-05 |
Abbott Laboratories |
Mammalian expression systems for hcv proteins
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
BR9305435A
(pt)
*
|
1992-03-06 |
1994-12-27 |
Innogenetics Nv |
Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
|
US5866139A
(en)
*
|
1992-06-04 |
1999-02-02 |
Institut Pasteur |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
|
JPH05344899A
(ja)
*
|
1992-06-11 |
1993-12-27 |
Kokuritsu Yobou Eisei Kenkyusho |
C型肝炎ウイルス外被タンパク質の産生法
|
UA39944C2
(uk)
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
DE69334328D1
(de)
|
1992-07-16 |
2010-06-10 |
Advanced Life Science Inst Inc |
Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
|
DE4240980A1
(de)
*
|
1992-08-07 |
1994-02-10 |
Boehringer Mannheim Gmbh |
HCV Peptidantigene und Verfahren zur Bestimmung von HCV
|
JPH06311885A
(ja)
*
|
1992-08-25 |
1994-11-08 |
Mitsubishi Kasei Corp |
C型肝炎ウイルス遺伝子に相補的なアンチセンス化合物
|
DE69330372T2
(de)
*
|
1992-09-10 |
2002-03-14 |
Isis Pharmaceuticals Inc |
ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
|
US6423489B1
(en)
*
|
1992-09-10 |
2002-07-23 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
AU5141993A
(en)
*
|
1992-09-28 |
1994-04-26 |
Chiron Corporation |
Methods and compositions for controlling translation of hcv proteins
|
US6057093A
(en)
*
|
1992-09-28 |
2000-05-02 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
JPH07501712A
(ja)
*
|
1992-09-29 |
1995-02-23 |
シーダーズ−サイナイ・メディカル・センター |
微量rnaまはたrnaおよびdna検出用の一段rnaおよび結合一段rnaおよびdnaポリメラーゼ・チェイン・リアクション
|
JPH06153959A
(ja)
*
|
1992-10-16 |
1994-06-03 |
Evernew Biotec Inc |
C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
AU6769594A
(en)
*
|
1993-04-22 |
1994-11-08 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
DE69434117T3
(de)
*
|
1993-05-10 |
2009-10-08 |
Novartis Vaccines and Diagnostics, Inc.(n.d.Ges.d.Staates Delaware), Emeryville |
Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
|
DE69433160T2
(de)
|
1993-05-12 |
2004-07-08 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region
|
US5610009A
(en)
*
|
1994-01-28 |
1997-03-11 |
Abbott Laboratories |
Mammalian expression systems for hepatitis C virus envelope genes
|
US5709995A
(en)
*
|
1994-03-17 |
1998-01-20 |
The Scripps Research Institute |
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
|
AU6946394A
(en)
*
|
1994-05-09 |
1995-11-29 |
Abbott Laboratories |
Method and reagents useful for improving immunoassay specificity
|
US6511812B1
(en)
|
1994-05-09 |
2003-01-28 |
Abbott Laboratories |
Method and test kit for use in improving immunoassay specificity
|
JPH10503364A
(ja)
*
|
1994-05-10 |
1998-03-31 |
ザ ジェネラル ホスピタル コーポレーション |
C型肝炎ウイルスのアンチセンス阻害
|
JP3217600B2
(ja)
|
1994-07-12 |
2001-10-09 |
株式会社先端生命科学研究所 |
非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
|
AU3241095A
(en)
*
|
1994-07-29 |
1996-03-04 |
Chiron Corporation |
Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
|
JPH09503396A
(ja)
|
1994-07-29 |
1997-04-08 |
インノジェネティクス・エヌ・ブイ |
診断用及び治療用の精製c型肝炎ウイルスエンベロープ蛋白
|
CA2195312A1
(en)
|
1994-07-29 |
1996-02-15 |
Mark Selby |
Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
|
DE4428705A1
(de)
*
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US6235888B1
(en)
|
1994-10-05 |
2001-05-22 |
The General Hospital Corporation |
Hepatitis C virus vaccine
|
PT804584E
(pt)
|
1994-10-21 |
2002-11-29 |
Innogenetics Nv |
Sequencias de virus da hepatite c genotipo 7 e sua utilizacao como agentes profilacticos terapeuticos e de diagnostico
|
ES2168456T3
(es)
*
|
1995-01-16 |
2002-06-16 |
North Sydney Area Health Serv |
Peptidos que afectan a los linfocitos t.
|
KR970010787A
(ko)
*
|
1995-08-14 |
1997-03-27 |
성재갑 |
B형 간염 바이러스 표면항원과 c형 간염 바이러스 외피 단백질의 융합 단백질 및 이를 포함하는 혼합 백신
|
US6127116A
(en)
*
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
GB9517926D0
(en)
|
1995-09-01 |
1995-11-01 |
Biocine Spa |
Binding protein
|
US5837442A
(en)
|
1995-11-29 |
1998-11-17 |
Roche Molecular Systems, Inc. |
Oligonucleotide primers for amplifying HCV nucleic acid
|
US5851759A
(en)
*
|
1996-04-19 |
1998-12-22 |
Chiron Corporation |
Heteroduplex tracking assay (HTA) for genotyping HCV
|
IT1284635B1
(it)
*
|
1996-04-24 |
1998-05-21 |
Clonit Spa |
Metodo per la rivelazione di acidi nucleici amplificati e kit per il suo uso.
|
JP3715027B2
(ja)
|
1996-05-07 |
2005-11-09 |
シスメックス株式会社 |
C型肝炎ウイルス感染症診断薬
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
FR2760458B1
(fr)
*
|
1997-03-05 |
1999-04-23 |
Bio Merieux |
Peptide structural antigenique, composes antigenique et immunogene et utilisations dans la detection, la prevention et le traitement d'une infection par le vhc
|
AU7471698A
(en)
|
1997-05-06 |
1998-11-27 |
Chiron Corporation |
Intracellular production of hepatitis c e1 and e2 truncated polypeptides
|
AU9363398A
(en)
|
1997-10-06 |
1999-04-27 |
Chiron S.P.A. |
Hepatitis c receptor protein cd81
|
CA2689696C
(en)
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
PT1154793E
(pt)
|
1999-02-26 |
2010-12-21 |
Novartis Vaccines & Diagnostic |
Utilização de bioadesivos e adjuvantes para a administração de antigénios nas mucosas
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
GB9927320D0
(en)
*
|
1999-11-18 |
2000-01-12 |
Chiron Spa |
Exosome separation
|
AU2001272945A1
(en)
*
|
2000-06-15 |
2001-12-24 |
Chiron Corporation |
Immunoassays for anti-hcv antibodies
|
EP1178116A1
(en)
*
|
2000-08-03 |
2002-02-06 |
Hybrigenics S.A. |
Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
|
RU2286172C2
(ru)
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
WO2002014362A2
(en)
|
2000-08-17 |
2002-02-21 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
EP1399183B1
(en)
|
2001-05-31 |
2010-06-30 |
Novartis Vaccines and Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
US7196183B2
(en)
|
2001-08-31 |
2007-03-27 |
Innogenetics N.V. |
Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
US7049060B2
(en)
*
|
2001-11-05 |
2006-05-23 |
Ortho-Clinical Diagnostics, Inc. |
HCV anti-core monoclonal antibodies
|
AU2003215316A1
(en)
|
2002-02-20 |
2003-09-09 |
Chiron Corporation |
Microparticles with adsorbed polypeptide-containing molecules
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
FR2839555B1
(fr)
*
|
2002-05-10 |
2007-07-27 |
Bio Rad Pasteur |
Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
|
FR2839722A1
(fr)
|
2002-05-17 |
2003-11-21 |
Bio Merieux |
Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
|
EP1546414B1
(en)
|
2002-09-09 |
2008-10-08 |
Novartis Vaccines and Diagnostics, Inc. |
Hcv assay
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
CA3081071A1
(en)
|
2002-10-16 |
2004-04-29 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
WO2004060396A2
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
PT1592441E
(pt)
|
2003-02-06 |
2012-05-21 |
Aduro Biotech |
Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização
|
KR101173871B1
(ko)
|
2003-02-06 |
2012-08-16 |
앤저 테라퓨틱스 인코퍼레이티드 |
변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
US8124747B2
(en)
|
2003-08-29 |
2012-02-28 |
Innogenetics |
HCV clade and prototype sequences thereof
|
WO2006070028A1
(es)
*
|
2004-12-23 |
2006-07-06 |
Berthet Francois Xavier |
Composiciones y procedimientos para detectar infección patógena
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
EP2612679A1
(en)
|
2004-07-29 |
2013-07-10 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
WO2006024020A2
(en)
|
2004-08-27 |
2006-03-02 |
Novartis Vaccines And Diagnostics Inc. |
Hcv non-structural protein mutants and uses thereof
|
WO2006039326A2
(en)
*
|
2004-09-29 |
2006-04-13 |
The Administrators Of The Tulane Educational Fund |
Inhibitors of hepatitits c virus
|
WO2007031867A2
(en)
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
A hepatitis c virus non-stru tural ns3/4a fusion gene
|
EP2138483B1
(en)
|
2007-03-20 |
2011-05-18 |
Terumo Kabushiki Kaisha |
Oxidative color-developing compounds, salts thereof, process for production of the same, reagent compositions and test tools made by using the same
|
US20090214593A1
(en)
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
US8071561B2
(en)
|
2007-08-16 |
2011-12-06 |
Chrontech Pharma Ab |
Immunogen platform
|
US8815253B2
(en)
|
2007-12-07 |
2014-08-26 |
Novartis Ag |
Compositions for inducing immune responses
|
CA2724649A1
(en)
|
2008-05-19 |
2009-11-26 |
Anza Therapeutics, Inc. |
Compositions comprising prfa* mutant listeria and methods of use thereof
|
US20120100171A1
(en)
|
2009-03-09 |
2012-04-26 |
William Henry |
Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
|
CA2766907A1
(en)
|
2009-07-06 |
2011-01-13 |
Novartis Ag |
Self replicating rna molecules and uses thereof
|
JP6025721B2
(ja)
|
2010-07-06 |
2016-11-16 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
RU2606846C2
(ru)
|
2011-07-06 |
2017-01-10 |
Новартис Аг |
Эмульсии типа "масло в воде", которые содержат нуклеиновые кислоты
|
ES2702318T3
(es)
|
2011-07-06 |
2019-02-28 |
Glaxosmithkline Biologicals Sa |
Emulsiones catiónicas de aceite en agua
|
AU2012322704B2
(en)
|
2011-10-11 |
2017-09-07 |
Novartis Ag |
Recombinant self-replicating polycistronic RNA molecules
|
RU2667429C2
(ru)
*
|
2013-05-10 |
2018-09-19 |
Соединенные Штаты Америки, В Лице Секретаря, Департамента Здравоохранения И Социального Обеспечения Сша |
Композиции и способы для одновременного обнаружения hcv антигена/антитела
|
RU2568872C1
(ru)
*
|
2014-10-15 |
2015-11-20 |
Игорь Геннадьевич Сивов |
Лекарственное средство для лечения вирусного гепатита с
|
BR112017010180B1
(pt)
|
2014-11-27 |
2022-10-04 |
Kimberly-Clark Worldwide, Inc |
Método para detectar a presença de norovírus, e, dispositivo de ensaio de fluxo contínuo para detecção de norovírus em uma amostra
|
WO2016160046A1
(en)
|
2015-03-27 |
2016-10-06 |
Ortho-Clinical Diagnostics, Inc. |
Hcv ns4a/modified ns3 polypeptides and uses thereof
|
CN109071665B
(zh)
|
2016-04-18 |
2022-11-01 |
塞德斯医疗公司 |
结合人cd40的激动性抗体及其用途
|